Ocuphire Pharma Inc

NASDAQ:OCUP   3:59:52 PM EDT
2.01
-0.03 (-1.47%)
Earnings Announcements

Ocuphire Pharma Announces Financial Results For First Quarter 2022

Published: 05/13/2022 12:12 GMT
Ocuphire Pharma Inc (OCUP) - Ocuphire Pharma Announces Financial Results for First Quarter 2022 and Provides Corporate Update.
Q1 Loss per Share $0.35.
Ocuphire Pharma - Based on Current Projections, Management Believes Current Cash on Hand Will Be Sufficient to Fund Operations Into the Q2 of 2023.
Q1 Earnings per Share View $-0.35 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.33

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.35

More details on our Analysts Page.